We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
-10.23%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$825M
Cap. Flow
-$625M
Cap. Flow %
-53.2%
Top 10 Hldgs %
49.79%
Holding
373
New
33
Increased
60
Reduced
133
Closed
84

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$23.3M
2
PG icon
Procter & Gamble
PG
+$22.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$19.6M
4
LMT icon
Lockheed Martin
LMT
+$11.6M
5
CTAS icon
Cintas
CTAS
+$10.9M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$54.1M
2
RTN
Raytheon Company
RTN
+$45.9M
3
USB icon
US Bancorp
USB
+$44.5M
4
SHW icon
Sherwin-Williams
SHW
+$42.8M
5
BDX icon
Becton Dickinson
BDX
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 21.51%
2 Consumer Discretionary 15.87%
3 Consumer Staples 11.28%
4 Industrials 11.18%
5 Healthcare 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXON
151
Axon Enterprise
AXON
$42.1B
$354K 0.03%
5,000
-1,000
-17% -$74.9K
GILD icon
152
Gilead Sciences
GILD
$162B
$353K 0.03%
+4,719
New +$326K
AVGO icon
153
Broadcom
AVGO
$2T
$350K 0.03%
14,780
-5,750
-28% -$162K
MTD icon
154
Mettler-Toledo International
MTD
$28.5B
$345K 0.03%
500
ABB
155
DELISTED
ABB Ltd
ABB
$345K 0.03%
20,000
-5,000
-20% -$109K
VMC icon
156
Vulcan Materials
VMC
$36.5B
$344K 0.03%
3,180
-185,812
-98% -$23.7M
ORA icon
157
Ormat Technologies
ORA
$6.6B
$338K 0.03%
5,000
BF.B icon
158
Brown-Forman Class B
BF.B
$13B
$333K 0.03%
6,000
-2,000
-25% -$129K
CL icon
159
Colgate-Palmolive
CL
$74.1B
$332K 0.03%
5,000
NXPI icon
160
NXP Semiconductors
NXPI
$58.4B
$332K 0.03%
4,000
LULU icon
161
lululemon athletica
LULU
$14.2B
$329K 0.03%
1,735
-600
-26% -$134K
FMS icon
162
Fresenius Medical Care
FMS
$12.8B
$328K 0.03%
10,000
TDY icon
163
Teledyne Technologies
TDY
$31.9B
$327K 0.03%
+1,100
New +$378K
FSLR icon
164
First Solar
FSLR
$26.2B
$325K 0.03%
9,000
-2,000
-18% -$95.1K
ERIC icon
165
Ericsson
ERIC
$33.3B
$324K 0.03%
40,000
RDY icon
166
Dr. Reddy's Laboratories
RDY
$10.1B
$323K 0.03%
40,000
TTWO icon
167
Take-Two Interactive
TTWO
$43.5B
$323K 0.03%
2,720
-300
-10% -$35.5K
OSK icon
168
Oshkosh
OSK
$9.47B
$322K 0.03%
5,000
+1,000
+25% +$78.4K
LNN icon
169
Lindsay Corp
LNN
$1.17B
$321K 0.03%
3,500
VRTX icon
170
Vertex Pharmaceuticals
VRTX
$123B
$321K 0.03%
1,351
+200
+17% +$45.9K
SQM icon
171
Sociedad Química y Minera de Chile
SQM
$20.7B
$316K 0.03%
14,000
ROP icon
172
Roper Technologies
ROP
$39.3B
$312K 0.03%
1,000
NOK icon
173
Nokia
NOK
$52.6B
$310K 0.03%
100,000
PUK icon
174
Prudential
PUK
$34.7B
$310K 0.03%
12,888
-1,546
-11% -$49.2K
VTV icon
175
Vanguard Morningstar Value ETF
VTV
$191B
$308K 0.03%
3,457
-275
-7% -$30.2K

Similar funds

R.H. Bluestein & Co's Q1 2020 Portfolio in Review

As of Q1 2020, R.H. Bluestein & Co held 373 positions worth $1.18B, down 41% from $2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

R.H. Bluestein & Co withdrew a net $625M in Q1 2020, closing 84 positions and reducing 133 holdings. Its most notable exit was ConocoPhillips, an estimated $54.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, R.H. Bluestein & Co opened a new position in Cintas worth $7.23M.

  • R.H. Bluestein & Co's largest Q1 2020 buy was Cintas: 166,904 shares worth $7.23M.
  • R.H. Bluestein & Co added most to Chevron in Q1 2020, an estimated $23.3M increase.
  • R.H. Bluestein & Co's biggest Q1 2020 reduction was Raytheon Company, cutting an estimated $45.9M.
  • R.H. Bluestein & Co fully exited ConocoPhillips in Q1 2020, selling an estimated $54.1M.
  • R.H. Bluestein & Co's ten largest holdings make up 50% of its $1.18B portfolio in Q1 2020.
  • R.H. Bluestein & Co opened 33 new positions and closed 84 in Q1 2020.
  • R.H. Bluestein & Co's portfolio value fell 41% quarter-over-quarter to $1.18B.

Based on R.H. Bluestein & Co's 13F filing for Q1 2020, filed 12 May 2020.